Additional climate targets for 2030 include increased renewable energy use at PUMA’s core suppliers and a focus on increasing ...

XELA Robotics Co., Ltd., (“XELA”), a pioneer in tactile sensing and advanced tactile AI-driven robotic solutions, today ...

Bioptimus, a leading AI company building the Foundation Model for biology, is thrilled to announce the appointment of ...

Recent launches of AI PCs for the global market with Lenovo AI Now have also been received positively. For enterprise AI, the Group is leveraging its full-stack hybrid infrastructure as well as Lenovo ...

Conexus MedStaff, a leader in international healthcare recruitment, is proud to partner with Taimaka, an organization providing critical malnutrition care to children in Gombe state, Nigeria.

For the first time, Allianz placed among the 25 World's Best Workplaces 2024™ at #17. The respected annual employer ranking conducted by Great Place To Work ® measures trust in employers and is based ...

NTT DATA, a global digital business and IT services leader, today released the first results of its extensive original research that reveals “playtime is over” for GenAI. The results overwhelmingly ...

Andersen Global strengthens its platform in New Zealand through a Collaboration Agreement with Three Sixty Capital Partners, a strategic M&A advisory firm based in Auckland.

The X-ray Laboratory of Rigaku Corporation, a Rigaku Holdings Group company and a global solution partner for X-ray analysis (headquarters: Akishima, Tokyo; president and CEO: Jun Kawakami; “Rigaku”), ...

“This is a great recognition,” said Brian Cassin, Chief Executive Officer of Experian. “It’s a testament to the hard work, dedication, and creativity that our employees worldwide bring to our company ...

BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global oncology company, today announced its intent to change the Company’s name to BeOne Medicines Ltd., confirming its commitment to develop ...

Oncology Focus : CAR-T and CAR-NK therapies represent ~30% of all cell and gene trials, with a strong focus on solid and hematological malignancies. Significant attention on gastrointestinal tract and ...